Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Motor Activity 1Disease 1Depression 1Body Weight Changes 1Body Weight 1Anxiety Disorders 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Professional Autonomy × Clear all
NCT02030353 2016-01-20

The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
35 enrolled
Breast

Body Weight, Body Weight Changes, Breast Neoplasms

NCT02468050 2015-06-10

Study of Exercise to Manage Distress During Breast Screening

University of Western Ontario, Canada

Phase 2 Completed
7 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression, Disease, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡